Skinopathy Recognized as a Top 20 Early Company in Canada

TORONTO, February 14, 2024 – Skinopathy, a fast growing innovator in dermatology, is thrilled to announce it has been selected as one of the 2024 Top 20 Early Companies named by the Canadian Innovation Exchange. This award recognizes and highlights the Skinopathy commitment to using Data & AI to revolutionize dermatology in Canada and abroad.

Skinopathy CEO and Co-Founder, Keith Loo, will be on stage at CIX Summit in Toronto to showcase their groundbreaking work and how they are leveraging cutting edge data analytics, artificial intelligence to make healthcare more accessible and efficient. The presentation promises to give insight on how Skinopathy is reshaping the future of healthcare for both patients and healthcare practitioners, alike.

In addition to the presentation, Skinopathy will be available in the Top 20/10 Lounge to provide attendees with the opportunity to ask questions and learn about the company’s innovative technologies.

“We are honoured to be recognized as a Top 20 Early Company,” says Loo. “Seeing the dedication of our doctors, data scientists, engineers, and administrators being recognized in this way validates our vision and hard work.”

Do not miss the opportunity to join Skinopathy in celebrating this milestone achievement and do not hesitate to catch Mr. Loo’s presentation or visit Skinopathy in the Top 20/10 Lounge on Wednesday March 27, 2024.

UPDATE: Watch Skinopathy CEO, Keith Loo, ring the TMX Bell as part of the CIX Top 20 Festivities.

Contact
Richard Pietro
Partnerships Lead
richard@skinopathy
833-272-7546

About Skinopathy
Skinopathy is a Canadian medtech company that is modernizing how healthcare practitioners, pharmaceuticals, and cosmeceuticals are screening, tracking, and managing all skin conditions.

It was started during the pandemic when Co-Founder, Dr. Colin Hong, noticed patients were coming to his clinic presenting with late-stage skin cancer due to delayed and/or canceled skin cancer screenings.

Not only were people’s well-being at stake, but he knew that these delays would only get worse
and stretch an already taxed healthcare system to its limits.

That is when he decided to collaborate with technologist and entrepreneur, Keith Loo, MBA,
to revolutionize, digitize, and automate the entire dermatological journey. Everything from
screening to research.

www.skinopathy.com

About GetSkinHelp
GetSkinHelp is a teledermatology platform that leverages Skinopathy technologies on any mobile device to provide virtual consultations, skin cancer / skin disease screening, advanced triaging and differential diagnosis for a complete circle of connected virtual care.

www.getskinhelp.com

Download on Apple and Android

more insights